Series C - Imperative Care

Series C - Imperative Care

Investment Firm

Overview

Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.

Announced Date

Dec 10, 2019

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

Bain Capital Life Sciences

Bain Capital Life Sciences

Bain Capital Life Sciences is a early_stage_venture and private_equity and venture firm.

Ally Bridge Group

Ally Bridge Group

Ally Bridge Group is a early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Participant Investors

6

Investor Name
Participant InvestorDelos Capital
Participant InvestorRock Springs Capital
Participant InvestorAlly Bridge Group
Participant InvestorBain Capital Life Sciences
Participant InvestorAscension Ventures

Round Details and Background

Imperative Care raised $85000000 on 2019-12-10 in Series C

Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 10, 2019
Series C - Imperative Care
6-85.0M
Jul 15, 2021
Series D - Imperative Care
9-260.0M
Jan 01, 2021
Debt Financing - Imperative Care
-40.0M
Jul 25, 2024
Series E - Imperative Care
11-150.0M

Recent Activity

There is no recent news or activity for this profile.